Molecular Study on Dengue Viruses of Patients in A Tertiary Care Hospital in Western Odisha

Authors

  • Sudipta kumar Ram
  • Sasmita Khatua
  • Sasmita Hotta

Keywords:

Dengue virus, Serotyping, ELISA, RT-PCR, DENV-2, Molecular diagnostics

Abstract

Background: As a viral disease caused by the Flavivirus transmitted by mosquitoes, Dengue is a common illness in tropical and subtropical countries with clinical manifestations from mild fever to complicated forms like Dengue Hemorrhagic Fever (DHF) and Dengue Shock Syndrome (DSS). Early diagnosis and specificity are important because there is no specific antiviral therapy or licensed vaccine available.

Aim: To assess the usefulness of molecular diagnostics in dengue virus serotyping and correlate results with clinical and demographic profiles.

Materials and Methods: 384 clinically suspected dengue patients according to WHO criteria were included. Serum was screened for antigen and antibodies by rapid tests and ELISA. Samples that were NS1 positive were also subjected to RT-PCR for detection of viral RNA and serotyping.

Results: 70 ELISA positives were seen out of 384 samples. RT-PCR verification of DENV-1 and DENV-2 serotypes was seen, with the predominance of DENV-2. Infection was mostly seen in males, and among the male population, 15–30 years was most affected. The post-monsoon season saw the maximum cases, specifically in the month of October. The most frequent symptoms that were seen were fever, headache, myalgia, arthralgia, and manifestations of bleeding.

Conclusion: ELISA is still a useful screening tool, and RT-PCR is useful for precise serotyping for effective surveillance. DENV-2 predominance with more severe clinical manifestations highlights the importance of ongoing vigilance and early detection, especially during peak risk periods.

Downloads

Download data is not yet available.

References

Gubler DJ. The Global Emergence / Resurgence of Arboviral Diseases As Public Health Problems. Arch Med Res.2002;33(4):330–42.

Dengue guidelines for diagnosis,treatment prevention and control.World health organisation (WHO). New edition2009.

Gubler DJ. Dengue and dengue hemorrhagic fever, 1996. Epidemiology Bull [Internet].1996;17(4):12–4.

Col L, Mustafa MS, Rasotgi C V, Jain CS, Col L, Gupta V. Science direct Discovery of fifth serotype of dengue virus ( DENV-5 ): A new public health dilemma in dengue control. Med J Armed Forces India. 2015 Jan; 71(1):67–70.

Goncalvez AP, Escalante AA, Pujol FH, Ludert JE, Tovar D, Salas RA, et al. Diversity and evolution of the envelope gene of dengue virus type 1. Virology. 2002;303(1):110–9.

Waman VP, Kolekar P, Ramtirthkar MR, Kale MM, Kulkarni-Kale U. Analysis of genotype diversity and evolution of Dengue virus serotype 2 using complete genomes. PeerJ.2016;4:2326.

Amarilla AA, De Almeida FT, Jorge DM, Alfonso HL, De Castro-Jorge LA,Nogueira NA, et al. Genetic diversity of the e Protein of Dengue Type 3 Virus. Virol J. 2009;6:1–13.

Cecilia D, Kakade MB, Bhagat AB, Vallentyne J, Singh A, Patil JA, et al. Detection of dengue-4 virus in Pune, western India after an absence of 30 years - Itsassociation with two severe cases. Virol J.2011;8:2–5.

Tygi BK,Hiriyan J,Samuel P,Tiwari SC,Paramasivan R. Dengue in Kerala: A Critical Review. ICMR. 2006;36 No.4-5(April-May):13–28.

Martina BEE, Koraka P, Osterhaus ADME. Dengue Virus Pathogenesis : an Integrated View. 2009;22(4):564–81

Limon-Flores AY, Perez-Tapia M, Estrada-Garcia I, Vaughan G, Escobar- Gutierrez A, Calderon-Amador J, et al.Virus inoculation to human skin explants: an effective approach to assess in situ the early infection and the effects on cutaneous dendritic cells. Int J Exp Pathol.2005;86(5):323–34.

Wu SJ, Grouard-Vogel G, Sun W, Mascola JR, Brachtel E, Putvatana R, et al. Human skin Langerhans cells are targets of dengue virus infection. Nat Med.2000;6(7):816–20.

Libraty DH, Pichyangkul S, Ajariyakhajorn C, Endy TP, Ennis FA. Human Dendritic Cells Are Activated by Dengue Virus Infection: Enhancement by GammaInterferon and Implications for Disease Pathogenesis. J Virol. 2002;75(8):3501–8.

Chen Y, Wang S. Activation of Terminally Differentiated Human Monocytes / Macrophages by Dengue Virus : Productive Infection, Hierarchical Production of Innate Cytokines and Chemokines, and the Synergistic Effect of Lipopolysaccharide. J. Virol.2002;76(19):9877–87

Luplertlop N, Misse D, Bray D, Deleuze, V, Gonzalez, JP, Leardkamolkarn V, et al. Dengue-virus-infected dendritic cells trigger vascular leakage through metalloproteinase overproduction. EMBO reports, 2006;7(11):1176–81

Downloads

Published

2025-10-16

How to Cite

1.
Ram S kumar, Khatua S, Hotta S. Molecular Study on Dengue Viruses of Patients in A Tertiary Care Hospital in Western Odisha. J Neonatal Surg [Internet]. 2025 Oct. 16 [cited 2026 Apr. 14];14(32S):8925-33. Available from: https://jneonatalsurg.com/index.php/jns/article/view/9364